Triamcinolone News
Study links age, gender to elevated IOP after triamcinolone injections
Age younger than 60 years and female gender may be risk factors for elevated IOP after intravitreal steroid therapy to treat inflammatory, neovascular, proliferative and edematous diseases, according to a study by researchers in...
Combined bevacizumab, triamcinolone show short-term efficacy for AMD-related neovascularization
In the short term, combined intravitreal bevacizumab and triamcinolone may reduce foveal edema and subfoveal fluid in patients with neovascularization due to age-related macular degeneration, according to a study by a researcher...
PDT with intravitreal steroid injection shows efficacy against neovascular AMD
Intravitreal injections of triamcinolone acetonide combined with photodynamic therapy may be more effective than PDT alone for stabilizing vision and reducing treatment frequency for patients with occult or minimally classic...
Triamcinolone acetonide decreased macular thickness in eyes with DME
Triamcinolone acetonide injected into the posterior sub-Tenon capsule can reduce the central macular thickening caused by diabetic macular edema, at least in the short term, according to a small study by researchers in Japan.
Whole blood keeps triamcinolone acetonide particles out of macular holes
Applying autologous whole blood before performing triamcinolone acetonide-assisted peeling of the internal limiting membrane may prevent triamcinolone particles from being deposited in macular holes, a study found. Use of the...